Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
International Journal of Chronic Obstructive Pulmonary Disease|February 12, 2011
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary diseaseAnand A Dalal, Melissa H Roberts, Hans V Petersen, et al.Health Services Research|May 20, 2004
Use of midlevel practitioners to achieve labor cost savings in the primary care practice of an MCODouglas W Roblin, David H Howard, Edmund R Becker, et al.Journal of the American Pharmacists Association : Japha|October 3, 2018
Pharmacist perceptions of the New Mexico pharmacist-performed tuberculosis testing programStefanie J Logothetis, Matthew E Borrego, Melissa H Roberts, et al.BMC Pulmonary Medicine|May 1, 2016
A retrospective analysis to identify predictors of COPD-related rehospitalizationMelissa H Roberts, Emmanuelle Clerisme-Beaty, Chris M Kozma, et al.Personalized Medicine|November 1, 2022
Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experimentCheng Chen, Melissa H Roberts, Dennis W Raisch, et al.Scientific Reports|April 9, 2022
Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndromeAmanda H Mahnke, Melissa H Roberts, Lawrence Leeman, et al.The American Journal of Managed Care|July 22, 2010
Can outpatient pharmacy data identify persons with undiagnosed COPD?Douglas W Mapel, Hans Petersen, Melissa H Roberts, et al.Annals of the American Thoracic Society|December 5, 2014
Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patientsAkshay A Kharat, Matthew E Borrego, Dennis W Raisch, et al.Pediatric Research|August 10, 2022
Early developmental trajectory of children with prenatal alcohol and opioid exposureJean R Lowe, Jared DiDomenico, Julia M Stephen, et al.Drugs - Real World Outcomes|October 18, 2016
Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis MethodsMelissa H Roberts, Douglas W Mapel, Matthew E Borrego, et al.Pageof 6